Metraipolis › archive › dc_69fea31be585

Targeted Inhibition of CD74+ Macrophages by Luteolin via CEBPB/P65 Signaling Ameliorates Osteoarthritis Progression — Europe PMC PMID:41268703

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41268703
DOI
10.1002/advs.202508472
License (as archived)
solo-consultazione
Archived
2026-11-08T08:36:53.637Z
SHA-256 of the archived text
8bd66d0aa0cc44570e2eb72361500b4028740d84514e98cad24b68bb5c7af24b
Stable URL of this page
https://metraipolis.com/documento/dc_69fea31be585

How to cite

Targeted Inhibition of CD74+ Macrophages by Luteolin via CEBPB/P65 Signaling Ameliorates Osteoarthritis Progression — Europe PMC PMID:41268703 — Europe PMC (en), https://europepmc.org/article/MED/41268703 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_69fea31be585 (Metraipolis archive dc_69fea31be585, sha256 8bd66d0aa0cc44570e2eb72361500b4028740d84514e98cad24b68bb5c7af24b)
BibTeX
@misc{dc69fea31be585,
  title = {Targeted Inhibition of CD74+ Macrophages by Luteolin via CEBPB/P65 Signaling Ameliorates Osteoarthritis Progression — Europe PMC PMID:41268703},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41268703},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_69fea31be585; sha256 8bd66d0aa0cc44570e2eb72361500b4028740d84514e98cad24b68bb5c7af24b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41268703. Agents can read the archived copy with the MCP tool read_document.